201 related articles for article (PubMed ID: 19475693)
1. Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex.
Lucena MI; Andrade RJ; Kaplowitz N; García-Cortes M; Fernández MC; Romero-Gomez M; Bruguera M; Hallal H; Robles-Diaz M; Rodriguez-González JF; Navarro JM; Salmeron J; Martinez-Odriozola P; Pérez-Alvarez R; Borraz Y; Hidalgo R;
Hepatology; 2009 Jun; 49(6):2001-9. PubMed ID: 19475693
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.
Andrade RJ; Lucena MI; Fernández MC; Pelaez G; Pachkoria K; García-Ruiz E; García-Muñoz B; González-Grande R; Pizarro A; Durán JA; Jiménez M; Rodrigo L; Romero-Gomez M; Navarro JM; Planas R; Costa J; Borras A; Soler A; Salmerón J; Martin-Vivaldi R;
Gastroenterology; 2005 Aug; 129(2):512-21. PubMed ID: 16083708
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Outcome of Drug-Induced Liver Injury in the Older Patients: From the Young-Old to the Oldest-Old.
Weersink RA; Alvarez-Alvarez I; Medina-Cáliz I; Sanabria-Cabrera J; Robles-Díaz M; Ortega-Alonso A; García-Cortés M; Bonilla E; Niu H; Soriano G; Jimenez-Perez M; Hallal H; Blanco S; Kaplowitz N; Lucena MI; Andrade RJ
Clin Pharmacol Ther; 2021 Apr; 109(4):1147-1158. PubMed ID: 33179256
[TBL] [Abstract][Full Text] [Related]
4. Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry.
Andrade RJ; Lucena MI; Kaplowitz N; García-Muņoz B; Borraz Y; Pachkoria K; García-Cortés M; Fernández MC; Pelaez G; Rodrigo L; Durán JA; Costa J; Planas R; Barriocanal A; Guarner C; Romero-Gomez M; Muņoz-Yagüe T; Salmerón J; Hidalgo R
Hepatology; 2006 Dec; 44(6):1581-8. PubMed ID: 17133470
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry.
Stephens C; Robles-Diaz M; Medina-Caliz I; Garcia-Cortes M; Ortega-Alonso A; Sanabria-Cabrera J; Gonzalez-Jimenez A; Alvarez-Alvarez I; Slim M; Jimenez-Perez M; Gonzalez-Grande R; Fernández MC; Casado M; Soriano G; Román E; Hallal H; Romero-Gomez M; Castiella A; Conde I; Prieto M; Moreno-Planas JM; Giraldez A; Moreno-Sanfiel JM; Kaplowitz N; Lucena MI; Andrade RJ;
J Hepatol; 2021 Jul; 75(1):86-97. PubMed ID: 33539847
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and pathological features in 138 cases of drug-induced liver injury].
Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136
[TBL] [Abstract][Full Text] [Related]
7. Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain.
Lucena MI; Andrade RJ; Fernández MC; Pachkoria K; Pelaez G; Durán JA; Villar M; Rodrigo L; Romero-Gomez M; Planas R; Barriocanal A; Costa J; Guarner C; Blanco S; Navarro JM; Pons F; Castiella A; Avila S;
Hepatology; 2006 Oct; 44(4):850-6. PubMed ID: 17006920
[TBL] [Abstract][Full Text] [Related]
8. Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry.
Medina-Caliz I; Garcia-Cortes M; Gonzalez-Jimenez A; Cabello MR; Robles-Diaz M; Sanabria-Cabrera J; Sanjuan-Jimenez R; Ortega-Alonso A; García-Muñoz B; Moreno I; Jimenez-Perez M; Fernandez MC; Ginés P; Prieto M; Conde I; Hallal H; Soriano G; Roman E; Castiella A; Blanco-Reina E; Montes MR; Quiros-Cano M; Martin-Reyes F; Lucena MI; Andrade RJ;
Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1495-1502. PubMed ID: 29307848
[TBL] [Abstract][Full Text] [Related]
9. [Prevalence and risk factors of drug induced liver disease: a survey based study in pharmacies].
Jüngst C; Gräber S; Klahn D; Wedemeyer H; Lammert F
Z Gastroenterol; 2016 Feb; 54(2):131-8. PubMed ID: 26854832
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced liver injury.
Leise MD; Poterucha JJ; Talwalkar JA
Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
[TBL] [Abstract][Full Text] [Related]
11. Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury.
Lucena MI; Andrade RJ; Martínez C; Ulzurrun E; García-Martín E; Borraz Y; Fernández MC; Romero-Gomez M; Castiella A; Planas R; Costa J; Anzola S; Agúndez JA;
Hepatology; 2008 Aug; 48(2):588-96. PubMed ID: 18666253
[TBL] [Abstract][Full Text] [Related]
12. Analysis of IL-10, IL-4 and TNF-alpha polymorphisms in drug-induced liver injury (DILI) and its outcome.
Pachkoria K; Lucena MI; Crespo E; Ruiz-Cabello F; Lopez-Ortega S; Fernandez MA; Romero-Gomez M; Madrazo A; Durán JA; de Dios AM; Borraz Y; Navarro JM; Andrade RJ;
J Hepatol; 2008 Jul; 49(1):107-14. PubMed ID: 18485518
[TBL] [Abstract][Full Text] [Related]
13. Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids.
Robles-Diaz M; Gonzalez-Jimenez A; Medina-Caliz I; Stephens C; García-Cortes M; García-Muñoz B; Ortega-Alonso A; Blanco-Reina E; Gonzalez-Grande R; Jimenez-Perez M; Rendón P; Navarro JM; Gines P; Prieto M; Garcia-Eliz M; Bessone F; Brahm JR; Paraná R; Lucena MI; Andrade RJ; ;
Aliment Pharmacol Ther; 2015 Jan; 41(1):116-25. PubMed ID: 25394890
[TBL] [Abstract][Full Text] [Related]
14. Clinical course and outcomes of drug-induced liver injury: nimesulide as the first implicated medication.
Licata A; Calvaruso V; Cappello M; Craxì A; Almasio PL
Dig Liver Dis; 2010 Feb; 42(2):143-8. PubMed ID: 19625223
[TBL] [Abstract][Full Text] [Related]
15. Drug-Induced liver injury with hypersensitivity features has a better outcome: a single-center experience of 39 children and adolescents.
Devarbhavi H; Karanth D; Prasanna KS; Adarsh CK; Patil M
Hepatology; 2011 Oct; 54(4):1344-50. PubMed ID: 21735470
[TBL] [Abstract][Full Text] [Related]
16. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.
Björnsson ES; Bergmann OM; Björnsson HK; Kvaran RB; Olafsson S
Gastroenterology; 2013 Jun; 144(7):1419-25, 1425.e1-3; quiz e19-20. PubMed ID: 23419359
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI).
Pachkoria K; Lucena MI; Ruiz-Cabello F; Crespo E; Cabello MR; Andrade RJ;
Br J Pharmacol; 2007 Mar; 150(6):808-15. PubMed ID: 17279092
[TBL] [Abstract][Full Text] [Related]
18. Idiosyncratic drug hepatotoxicity: a 2008 update.
Andrade RJ; López-Ortega S; López-Vega MC; Robles M; Cueto I; Lucena MI
Expert Rev Clin Pharmacol; 2008 Mar; 1(2):261-76. PubMed ID: 24422651
[TBL] [Abstract][Full Text] [Related]
19. Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis.
Lucena MI; Kaplowitz N; Hallal H; Castiella A; García-Bengoechea M; Otazua P; Berenguer M; Fernandez MC; Planas R; Andrade RJ
J Hepatol; 2011 Oct; 55(4):820-7. PubMed ID: 21338638
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced liver injury: a cohort study on patients referred to the Danish transplant center over a five year period.
Baekdal M; Ytting H; Skalshøi Kjær M
Scand J Gastroenterol; 2017 Apr; 52(4):450-454. PubMed ID: 27973926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
